A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia.

Blood - United States
doi 10.1182/blood.v114.22.2324.2324
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Still a Role for Second-Line Chemoimmunotherapy in Chronic Lymphocytic Leukemia?

Haematologica
Hematology
2018English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Role of microRNA in Chronic Lymphocytic Leukemia Onset and Progression

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America
OncologyHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy